128 related articles for article (PubMed ID: 2596729)
21. Nosocomial blood-stream infection in patients with end-stage renal disease: excess length of hospital stay, extra cost and attributable mortality.
Liu JW; Su YK; Liu CF; Chen JB
J Hosp Infect; 2002 Mar; 50(3):224-7. PubMed ID: 11886200
[TBL] [Abstract][Full Text] [Related]
22. Hospital-acquired pneumonia. Attributable mortality and morbidity.
Leu HS; Kaiser DL; Mori M; Woolson RF; Wenzel RP
Am J Epidemiol; 1989 Jun; 129(6):1258-67. PubMed ID: 2729261
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteremia.
Lin YC; Chen TL; Ju HL; Chen HS; Wang FD; Yu KW; Liu CY
J Microbiol Immunol Infect; 2006 Feb; 39(1):67-72. PubMed ID: 16440126
[TBL] [Abstract][Full Text] [Related]
24. [Effect of nosocomial bacteremia caused by oxacillin-resistant Staphylococcus aureus on mortality and length of hospitalization].
Moreira M; Medeiros EA; Pignatari AC; Wey SB; Cardo DM
Rev Assoc Med Bras (1992); 1998; 44(4):263-8. PubMed ID: 9852643
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for nosocomial bacteremia in a large Spanish teaching hospital: a case-control study.
Trilla A; Gatell JM; Mensa J; Latorre X; Almela M; Soriano E; Jimenez de Anta MT; Garcia San Miguel J
Infect Control Hosp Epidemiol; 1991 Mar; 12(3):150-6. PubMed ID: 2022860
[TBL] [Abstract][Full Text] [Related]
26. Enterococcal bacteremia without endocarditis.
Shlaes DM; Levy J; Wolinsky E
Arch Intern Med; 1981 Apr; 141(5):578-81. PubMed ID: 6784687
[TBL] [Abstract][Full Text] [Related]
27. Endemic bacteremia in Columbia, South Carolina.
Bryan CS; Hornung CA; Reynolds KL; Brenner ER
Am J Epidemiol; 1986 Jan; 123(1):113-27. PubMed ID: 3940430
[TBL] [Abstract][Full Text] [Related]
28. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study.
Blot S; Vandewoude K; Colardyn F
Intensive Care Med; 2003 Mar; 29(3):471-5. PubMed ID: 12577148
[TBL] [Abstract][Full Text] [Related]
29. Hospital costs and mortality attributed to nosocomial bacteremias.
Spengler RF; Greenough WB
JAMA; 1978 Nov; 240(22):2455-8. PubMed ID: 712937
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance and impact on mortality of extended-spectrum beta lactamase-producing Enterobacteriaceae isolates in nosocomial bacteremia.
Menashe G; Borer A; Yagupsky P; Peled N; Gilad J; Fraser D; Riesenberg K; Schlaeffer F
Scand J Infect Dis; 2001; 33(3):188-93. PubMed ID: 11303808
[TBL] [Abstract][Full Text] [Related]
31. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit.
Digiovine B; Chenoweth C; Watts C; Higgins M
Am J Respir Crit Care Med; 1999 Sep; 160(3):976-81. PubMed ID: 10471627
[TBL] [Abstract][Full Text] [Related]
32. Enterococcal bacteremia in children: a review of seventy-five episodes in a pediatric hospital.
Das I; Gray J
Pediatr Infect Dis J; 1998 Dec; 17(12):1154-8. PubMed ID: 9877366
[TBL] [Abstract][Full Text] [Related]
33. Enterococcal bacteremia in a medical center.
Peng MY; Young TG; Yang CH; Chou MY
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Nov; 54(5):306-11. PubMed ID: 7834553
[TBL] [Abstract][Full Text] [Related]
34. The impact of nosocomial infections on patient outcomes following cardiac surgery.
Kollef MH; Sharpless L; Vlasnik J; Pasque C; Murphy D; Fraser VJ
Chest; 1997 Sep; 112(3):666-75. PubMed ID: 9315799
[TBL] [Abstract][Full Text] [Related]
35. Influence of matching for exposure time on estimates of attributable mortality caused by nosocomial bacteremia in critically ill patients.
Blot S; De Bacquer D; Hoste E; Depuydt P; Vandewoude K; De Waele J; Benoit D; De Schuijmer J; Colardyn F; Vogelaers D
Infect Control Hosp Epidemiol; 2005 Apr; 26(4):352-6. PubMed ID: 15865270
[TBL] [Abstract][Full Text] [Related]
36. Clinical and microbiological features of Providencia bacteremia: experience at a tertiary care hospital.
Choi HK; Kim YK; Kim HY; Park JE; Uh Y
Korean J Intern Med; 2015 Mar; 30(2):219-25. PubMed ID: 25750564
[TBL] [Abstract][Full Text] [Related]
37. [Enterococcal bacteremia at Nîmes university hospital].
Lavigne JP; Marchandin H; Czarnecki E; Kaye C; Sotto A
Pathol Biol (Paris); 2005; 53(8-9):539-45. PubMed ID: 16084034
[TBL] [Abstract][Full Text] [Related]
38. Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality.
Seifert H; Strate A; Pulverer G
Medicine (Baltimore); 1995 Nov; 74(6):340-9. PubMed ID: 7500897
[TBL] [Abstract][Full Text] [Related]
39. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia.
Lee NY; Lee HC; Ko NY; Chang CM; Shih HI; Wu CJ; Ko WC
Infect Control Hosp Epidemiol; 2007 Jun; 28(6):713-9. PubMed ID: 17520546
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case-control study.
Wisplinghoff H; Cornely OA; Moser S; Bethe U; Stützer H; Salzberger B; Fätkenheuer G; Seifert H
Infect Control Hosp Epidemiol; 2003 Dec; 24(12):905-11. PubMed ID: 14700405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
